We have identified more significant associations than were previously reported in IIM clinical subgroups, such as NAB1 and FAM167A‐BLK loci in PM and CCR5 in IBM, which also have prior evidence of association with rheumatic disease. This evidence concerns the gene CCR5 and inclusion body myositis.